Hello.

I am new to the med safety role & in need of some expert advice on a process that is new to our facility.

Our anesthesiologists assist with pain managment at our hospital and a new physician has a practice of having nurses dilute dilaudid 1mg in 10mL normal saline and infusing it over 15 minutes to avoid "patient conflation of opioid-induced euphoria vs. true analgesic benefit."

We are looking into using the ADD-vantage system. In watching the Pfizer video, it looks like the plug floats around in the bag after mixing and could potentially block the flow of the fluid during administration. Does anyone use these and have you ever found this to be a problem?

Thank you!

Hello,

There has been quite a bit of discussion around increasing characters required for product searches in ADCs. Have any institutions required minimum characters in CPOE as well? We are an epic institution and curious if others have considered this.

We are preparing for our Leapfrog survey (first one). In such were coming across the need to use Beers List, but have concerns with the amount of alert fatigue it may cause.

Specific questions for those that use it:
1. Do you use what is offered "out of the box" from your EMR? If so which one?
2. Do you treat all settings equally? Hospital, Ambulatory, LTC.
3. How do you reduce the noise to really get at the intended patients? This may be different for each setting.

Hi All - has anyone completed a compare/contrast or gap analysis related to the different manufacturers of infusion pumps? Was hoping to save some time if anyone has already completed this work.

Thanks!

For facilities that utilize ADC-prompted virtual rapid sequence intubation (RSI) kits, what best practices have you implemented? Including what has and hasn't worked.

Can anyone share how they have tackled their LASA policy/lists when it comes to addressing biosimilars and monoclonal antibodies. We think the nomenclature is easily confused and are evaluating possible safety impacts/look-alike, sound-alike risks as more of these products come to market. We would prefer to avoid blanket statements such as adding all monoclonal antibodies are at risk for LASA errors.
Thanks!

If you have a medication history team, what metrics/outcomes do you report out to share the value of the services?

We currently have a percentage of inpatient admissions covered by pharmacy, and was wondering if there is another way to look at impact.

Thanks in advance!

There seems to be some data out there that IV push of 500mg doses may be considered and is safe when compared to administering via IV infusion. Our current dose limit for administering thiamine IV push is 200mg but we are exploring increasing this to 500mg. What are other places doing? If anyone does allow thiamine 500mg IV push have you seen any safety concerns with it? Thanks!

Hello,
We are in the process of overhauling our personal insulin pump policy, order set, and process. We are interested in learning about how insulin pumps are handled within your institution/health system. If you are able, would love to see any clinical guidance, order set, or policy examples that you can share. Can you please answer the questions below:
1) Do you allow use of personal insulin pumps during acute admissions?
2) Exclusion criteria for personal insulin pump use (other than AMS or acuity
limiting ability to safely self-manage)?